Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 3/21/2003 First Published: 5/1/2000


1.		Phase I/II Study of MART-1 Peptide-Pulsed Dendritic Cell Immunotherapy in Patients With Stage IV or Relapsed Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				UCLA-9508375 NCI-H00-0050, NCT00005617

Last Modified: 7/24/2007 First Published: 6/1/2002


2.		Phase I/II Study of Vaccination With MART-1 Adenovirus-Transduced Dendritic Cells in Patients With Stage IV or Recurrent Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				Over 18				NCI				UCLA-9707074 NCI-G02-2077, NCT00039325

Last Modified: 5/31/2007 First Published: 1/1/1999


3.		Phase I Randomized Study of Peptide Pulsed Dendritic Cell Vaccine in Patients With Stage IV Melanoma (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				Over 18				NCI				UPCC-4697 NCI-T98-0033, NCT00003665, T98-0033

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute